Shopping News / Articles
Trading View
tradingview. com > news > reuters. com, 2026: newsml_L6 N40 S0 L7: 0-boston-oncology-in-cancer-drug-deal-with-china-s-xuanzhu-biopharmaceutical

Boston Oncology in cancer drug deal with China's Xuanzhu Biopharmaceutical

1+ hour, 31+ min ago  (24+ words) Trading View Boston Oncology in cancer drug deal with China's Xuanzhu Biopharmaceutical More news from Reuters...

The Asia Business Daily
asiae. co. kr > en > article > 2026040909160374410

SK Bioscience Holds '2026 SKY Vision Symposium"

10+ hour, 40+ min ago  (199+ words) SK Bioscience Holds '2026 SKY Vision Symposium' Published 09 Apr. 2026 09: 16(KST) SK Bioscience announced on April 9 that it held the '2026 SKY Vision Symposium' over two days from April 4 to 5 at the Oakwood Premier Hotel in Songdo, Incheon. Jae-Yong Ahn, President of SK…...

Royal Society of Chemistry
rsc. org > events > find-an-event > regulatory-considerations-for-pharmaceutical-manufacturing-process-models

Regulatory Considerations for Pharmaceutical Manufacturing Process Models

5+ hour, 26+ min ago  (238+ words) The Royal Society of Chemistry Regulatory Considerations for Pharmaceutical Manufacturing Process Models April webinar for PCTG The integration of process models into pharmaceutical manufacturing has gained considerable attention in recent years due to their potential to enhance efficiency, productivity, and…...

open PR. com
openpr. com > news > 4461773 > trends-in-growth-segment-analysis-and-competitive-strategies

Trends in Growth, Segment Analysis, and Competitive Strategies Influencing the Biotechnology Reagents Market

1+ hour, 33+ min ago  (53+ words) open PR. com We are establishing a secure connection. This website is using a security service to protect itself from online attacks. We are checking your browser to establish a secure connection and keep you safe. Performance & security by bunny....

open PR. com
openpr. com > news > 4462011 > top-players-and-competitive-overview-in-the-artificial

Top Players and Competitive Overview in the Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market

40+ min ago  (68+ words) open PR. com Top Players and Competitive Overview in the Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market Press release from: The Business Research Company Permanent link to this press release: You can edit or delete your press release Top…...

KBR
koreabiomed. com > news > article View. html

Jenecell inks stem cell deal with Healios to enter K-beauty market

4+ hour, 47+ min ago  (286+ words) Jenecell, the Korean offshoot of the Japanese healthcare company Alfresa Corporation, said it signed a 1. 4 billion won ($945, 000) contract with Healios, a Japanese regenerative medicine developer, to receive bone marrow-derived stem cell conditioned media. Through the agreement, Jenecell has secured a…...

open PR. com
openpr. com > news > 4461862 > future-perspectives-key-trends-shaping-the-catastrophic

Future Perspectives: Key Trends Shaping the Catastrophic Antiphospholipid Syndrome Market Until 2030

1+ hour, 13+ min ago  (52+ words) open PR. com We are establishing a secure connection. This website is using a security service to protect itself from online attacks. We are checking your browser to establish a secure connection and keep you safe. Performance & security by bunny....

Yahoo Finance
finance. yahoo. com > sectors > healthcare > articles > 1-05-bn-biopharmaceutical-cxo-100500598. html

$1. 05 Bn Biopharmaceutical CXO Markets - Global Forecast Report 2026-2032: How Leading Pharmas Such as Pfizer, Roche, Novartis, Sanofi, and Astra Zeneca Navigate the Evolving Dynamics

51+ min ago  (228+ words) Dublin, April 09, 2026 (GLOBE NEWSWIRE) -- The "Biopharmaceutical CXO Market - Global Forecast 2026-2032" report has been added to Research And Markets. com's offering. The Biopharmaceutical CXO Market grew from USD 655. 12 million in 2025 to USD 706. 90 million in 2026. It is expected to continue growing at…...

The Manila Times
manilatimes. net > 04/09/2026 > tmt-newswire > globenewswire > bdc-launches-a-150million-life-sciences-venture-fund > 2317016 > amp

BDC launches a $150million Life Sciences Venture Fund

2+ hour, 53+ min ago  (177+ words) BDC to support early'stage companies in therapeutics and medical technologies MONTREAL, April 09, 2026 (GLOBE NEWSWIRE) -- The Business Development Bank of Canada (BDC) today announced the launch of its $150'million'Life Sciences Venture Fund, created to support the next generation of Canadian companies…...

Market Screener
marketscreener. com > news > certain-options-of-leifras-co-ltd-are-subject-to-a-lock-up-agreement-ending-on-9-apr-2026-ce7e50dbda80ff25

Certain Options of Leifras Co. , Ltd. are subject to a Lock-Up Agreement Ending on 9-APR-2026.

10+ hour, 35+ min ago  (42+ words) marketscreener. com Miscellaneous Educational Service Providers Certain Options of Leifras Co. , Ltd. are subject to a Lock-Up Agreement Ending on 9-APR-2026....

Shopping

Please enter a search for detailed shopping results.